Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
TEVA Plunges on Q1 Results - TipRanks.com
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva Pharmaceuticals Q4 2016 Earnings
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Earnings Preview: What To Expect From Teva Pharmaceutical On Thursday
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates | Nasdaq
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Teva Pharmaceutical Industries Misses Q1 Earnings Estimates Maintains Forecast for 2023 - Best Stocks
Teva Pharmaceutical earnings per share 2006-2022 | Statista
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
Teva Earnings: Is It Time to Worry? | Barron's
